Descrizione Del Prodotto

Ossicodone HCl 20mg

Oxycodone HCl 20 mg is a strong prescription opioid analgesic designed to manage moderate-to-severe acute or chronic pain. Classified as a Schedule II controlled substance, it is clinically recommended when standard over-the-counter pain relievers or lower-dosage opioids fail to provide adequate pain relief.

How Oxycodone HCl 20 mg Works

Oxycodone acts on the central nervous system (CNS) by binding directly to $\mu$-opioid receptors located throughout the brain and spinal cord. This mechanism alters both the perception of pain and the emotional response to it, offering significant relief for complex conditions like post-operative recovery, severe injuries, or cancer-related pain.

Depending on the specific formulation prescribed:

• Immediate-Release (IR): Provides onset of pain relief within 15 to 30 minutes, peaking around one hour.

• Controlled-Release (CR): Releases the active medication gradually over 12 hours for continuous baseline pain control.

Dosing and Administration Guidelines

To ensure therapeutic effectiveness and reduce health risks, take Oxycodone HCl 20 mg exactly as directed by your physician.

Warning: Never stop taking Oxycodone abruptly if used regularly, as sudden discontinuation can induce acute opioid withdrawal symptoms.

Potential Side Effects and Safety Precautions

While highly effective for severe pain, Oxycodone 20 mg requires strict adherence to safety protocols due to potential adverse effects.

Common Adverse Effects

• Drowsiness, fatigue, or sedation

• Nausea, vomiting, or abdominal distress

• Chronic constipation

• Dry mouth, itching, and lightheadedness

Critical Health Risks

• Severe Respiratory Depression: Opioids can dangerously slow breathing rates, particularly during initial treatment or dosage increases.

• Risk of Addiction and Dependence: Prolonged administration can cause physical tolerance, dependence, and potential opioid use disorder.

• Dangerous Drug Interactions: Combining Oxycodone with alcohol, benzodiazepines, or other central nervous system depressants significantly heightens the risk of fatal respiratory arrest.